Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 25, 2013
Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumabTony M Keaveny, Michael R McClung, Harry K Genant, et al.
The Journal of Rheumatology|December 17, 2018
Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS)Féline P B Kroon, Sjoerd van Beest, Frédérique Gandjbakhch, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trialPierre D Delmas, Kristine E Ensrud, Jonathan D Adachi, et al.
The Journal of Rheumatology|February 17, 2015
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research PrioritiesMikkel Østergaard, Paul Bird, Frédérique Gandjbakhch, et al.
The Journal of Rheumatology|September 3, 2011
Development and preliminary validation of a magnetic resonance imaging joint space narrowing score for use in rheumatoid arthritis: potential adjunct to the OMERACT RA MRI scoring systemMikkel Ostergaard, Pernille Bøyesen, Iris Eshed, et al.
Skeletal Radiology|October 27, 2023
Revision of the 1994 World Health Organization T-score definition of osteoporosis for use in older East Asian women and men to reconcile it with their lifetime risk of fragility fractureYi Xiang J Wáng, James F Griffith, Glen M Blake, et al.
The Journal of Rheumatology|September 3, 2011
Update on research and future directions of the OMERACT MRI inflammatory arthritis groupPhilip G Conaghan, Fiona M McQueen, Paul Bird, et al.
Pharmacology, Biochemistry, and Behavior|July 1, 2008
Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced painCamilla I Svensson, Satyanarayana Medicherla, Shelle Malkmus, et al.
Lancet (London, England)|July 31, 2017
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trialBente L Langdahl, Cesar Libanati, Daria B Crittenden, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2002
Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defectMartin O Bergo, Bryant Gavino, Jed Ross, et al.
Pageof 15